Alinity m reagents and supplies OY1
Ended Awarded Last action
- Contract number
- 36C25923N0101
- Awardee
-
Abbott Molecular Inc. UEI NK5QDVJBHMN7 Part of Abbott Laboratories
- Awarding agency
-
Veterans Integrated Service Network 19
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $516,628
Award facts
- Contract value 19% obligated
-
- $516,628.48 Current, with exercised options
- $2,706,198.74 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Aurora, CO 80045, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$170,977 | |
| Supplemental Agreement for work within scope | $95,820 | |
| Original award | $591,785 |
About this award
Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a Blanket Purchase Agreement (BPA) call valued at $2.7 million by Veterans Integrated Service Network 19 on December 1, 2022, with an ultimate completion date of November 30, 2023. This firm fixed-price contract, issued under the General Services Administration's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) schedule, covers Alinity M reagents and supplies to be delivered to the VA facility in Aurora, Colorado. Abbott Molecular specializes in molecular diagnostic products and services, including advanced diagnostic equipment, reagents, and test kits for infectious disease screening. The contract does not include a small business set-aside designation, reflecting Abbott's status as a large, established medical technology corporation.
This award represents one of multiple indefinite delivery vehicles that Abbott Molecular maintains across federal healthcare agencies. The company holds several BPAs with various Veterans Integrated Service Networks valued between $1.3 million and $12.5 million for Alinity M diagnostic reagents and supplies, supporting critical molecular testing infrastructure for COVID-19, HIV, hepatitis C, and human papillomavirus screening across the VA system. The contract with VISN 19 is part of Abbott Molecular's broader portfolio of federal diagnostic contracts, which includes delivery orders valued at $4.5 million to $11 million issued through 2029 and 2030, demonstrating the company's entrenched position as a strategic supplier of diagnostic solutions to the federal healthcare system.
Quick answers
Who was awarded contract 36C25923N0101?
36C25923N0101 was awarded to Abbott Molecular Inc. by Veterans Integrated Service Network 19 (Veterans Health Administration) on December 1, 2022.
How much is contract 36C25923N0101 worth?
The government has obligated $516,628 on 36C25923N0101. Its potential value, with all options, is $2,706,199.
Is contract 36C25923N0101 an order under another contract?
Yes. 36C25923N0101 is a BPA call under V797D40222-36C25922A0005, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25923N0101 competed?
The extent of competition for 36C25923N0101 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award